Twist Bioscience shares are trading higher after Barclays maintained its Overweight rating and raised its price target on the stock from $65
Twist Bioscience shares are trading higher after Barclays maintained its Overweight rating and raised its price target on the stock from $65 to $95.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.